MPAM
OMGA

Murphy Pohlad Asset Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Murphy Pohlad Asset Management’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,500
Closed -$12.3K – 127
2024
Q4 		$12.3K Hold
16,500
– – 0.01% 121
2024
Q3 		$20.1K Hold
16,500
– – 0.01% 119
2024
Q2 		$34.2K Hold
16,500
– – 0.01% 114
2024
Q1 		$60.2K Hold
16,500
– – 0.02% 118
2023
Q4 		$49.7K Buy
+16,500
New +$33.4K 0.02% 115

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Murphy Pohlad Asset Management's OMGA Position: Q1 2025 in Review

Murphy Pohlad Asset Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 16,500 shares — an estimated $12.3K sold.

Murphy Pohlad Asset Management first reported a position in OMGA in Q4 2023 and held it in 5 quarters. The position peaked at $60.2K in Q1 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Murphy Pohlad Asset Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Murphy Pohlad Asset Management sold 16,500 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $12.3K.
  • Murphy Pohlad Asset Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q4 2023 and held it in 5 quarters.
  • Murphy Pohlad Asset Management's Omega Therapeutics, Inc. Common Stock position peaked at $60.2K in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Murphy Pohlad Asset Management's 13F filing for Q1 2025, filed 17 Apr 2025.